OncoTherapy Science, Inc.
OCTOBER 1, 2013

Announcement of patent registrations
OncoTherapy Science, Inc. (hereinafter, “OncoTherapy”) announces that OncoTherapy obtained thefollowing patents.

OncoTherapy will announce its issued patents every two or three months.

Patents reported here are those of which registration could be confirmed by OncoTherapy from August to
September in 2013.
[Patents for Peptide Vaccines]
Patent No. 8,541,546

Country: United States

Patent No. 8,530,430

Country: United States

Patent No. 8,535,942

Country: United States

Patent No. 102274

Country: Ukraine

Patent No. 2008215432

Country: Australia

Patent No. 593086

Country: New Zealand

Patent No. 307376

Country: Mexico

Patent No. 308686

Country: Mexico

Patent No. 308974

Country: Mexico

Patent No. 2289533

Country: Europe

Patent No. 2121731

Country: Europe

Patent No. ZL200780022547.X

Country: China

Patent No. 5339292

Country: Japan

Patent No. 5339375

Country: Japan

Patent No. 5320544

Country: Japan

OncoTherapy is proceeding with the research and development of cancer peptide vaccines which caninduce specific immune responses against cancer, and is conducting clinical trials using these cancer
peptide vaccines by themselves or jointly with its licensing partner companies.

The above patents

obtained by OncoTherapy are related to those peptide vaccines, and are expected to accelerate the clinicaldevelopments.
[Patents for Screening Methods of Cancer Drug Candidates]
Patent No. 8,512,944

Country: United States

Patent No. 5339291

Country: Japan

OncoTherapy is proceeding with the research and development of molecular target drugs which target
molecules associated with cancer growth.

The above patent obtained by OncoTherapy is related tomethods of screening for candidates of those molecular target drugs.
[A patent for Antibodies]
Patent No. ZL200980133688.8

Country: China

OncoTherapy is proceeding with the research and development of cancer therapeutic antibodies whichhave ability of binding to cancer cells and killing them.

The above patent obtained by OncoTherapy isrelating to these cancer therapeutic antibodies.
[A patent for methods of evaluating anti-cancer drug sensitivity]
Patent No. 5321780

Country: Japan

OncoTherapy is proceeding with the research and development of methods of selecting patients in whom
an anti-cancer drug is effective. The above patent obtained by OncoTherapy is relating to these methods ofevaluating anti-cancer drug sensitivity.
[A patent for a compact automatic emulsion-preparing device]
Patent No. 23954

Country: Cuba

The above patent obtained by OncoTherapy is relating to a compact automatic emulsion-preparing device
developed by OncoTherapy. Such device can prepare cancer peptide vaccines automatically, and reduce
physical burden of preparation work. OncoTherapy has granted the exclusive license to manufacture andsell this device to SEPPIC (Société d'Exploitation de Produits pour les Industries Chimiques) S.A.
(the release of July 29th, 2013), and this patent registration will secure stable manufacture andsale of the devices by SEPPIC S.A..

OncoTherapy will continue to strategically obtain patents for anti-cancer drug candidates, including
peptide vaccines, in order to promote the research and development of more effective and safer anti-cancerdrugs.